Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
Front Immunol. 2020 Mar 27;11:552. doi: 10.3389/fimmu.2020.00552. eCollection 2020.
Liver cancer is the third most common cause of cancer related death in the World. From an epidemiological point of view the risk factors associated to primary liver cancer are mainly viral hepatitis infection and alcohol consumption. Even though there is a clear correlation between liver inflammation, cirrhosis and cancer, other emerging liver diseases (like fatty liver) could also lead to liver cancer. Moreover, the liver is the major site of metastasis from colon, breast, ovarian and other cancers. In this review we will address the peculiar status of the liver as organ that has to balance between tolerance and immune activation. We will focus on macrophages and other key cellular components of the liver microenvironment that play a central role during tumor progression. We will also discuss how current and future therapies may affect the balance toward immune activation.
肝癌是全球第三大常见癌症死因。从流行病学角度来看,原发性肝癌的主要危险因素是病毒性肝炎感染和饮酒。尽管肝脏炎症、肝硬化和肝癌之间存在明显的相关性,但其他新兴的肝脏疾病(如脂肪肝)也可能导致肝癌。此外,肝脏是结肠癌、乳腺癌、卵巢癌等癌症转移的主要部位。在这篇综述中,我们将探讨肝脏作为一个在耐受和免疫激活之间保持平衡的器官的特殊状态。我们将重点讨论巨噬细胞和肝脏微环境中的其他关键细胞成分在肿瘤进展中的核心作用。我们还将讨论当前和未来的治疗方法如何影响免疫激活的平衡。